March 1, 2013

Diagnostic imaging of smart genetically engineered nanomedicines

Investigators: J. Andrew MacKay, Ph.D.; Peter Conti, M.D., Ph.D.
Innovation: developing a timepoint-independent pharmacokinetic modeling strategy
Clinical significance: improving personalized medicine by more accurately measuring the effects of a particular treatment on an individual patient
July 22, 2011

Telomerase Reprogramming Nanoparticles (TeRN): Design and Validation of a Universal Cancer Therapeutic

Investigators: Amir Goldkorn; Nicos Petasis
July 22, 2011

An Ultrasound-Activated Nanoparticle Vehicle for Selective Imaging and Drug Delivery

Investigators: Travis Williams; Andy Chang
July 22, 2011

Engineering Nanoparticles for Enhanced Cancer Therapeutics

Investigators: Pin Wang; Michael Wong